Practice Variation in Clinician Guidance Regarding Sport Participation in Congenital Heart Disease
Abstract Body (Do not enter title and authors here): Introduction: Athletic participation is increasing among individuals with congenital heart disease (CHD), but there are limited data to guide sports participation decision-making in this population. We conducted a survey to define practice variation in this area focusing on two complex populations post repair (Tetralogy of Fallot (TOF) and D-transposition of the great arteries s/p arterial switch (D-TGA)). Methods: An online survey was distributed by investigators to clinicians treating patients with CHD. Respondents were queried regarding their approach to specific complex congenital patient scenarios and sports participation. Results: A total of 165 cardiologists completed the survey, most (147/165, 89%) in academic practice. Respondents included 95/165 (58%) pediatric cardiologists, 59/165 (36%) adult congenital heart disease (ACHD) specialists, and 11/165 (7%) other subspecialties. TOF: Nearly all respondents (156/165, 95%) reported supporting full sport participation in individuals with well-repaired TOF (without residual lesion or cardiac dysfunction). With severe pulmonic regurgitation, support for full participation remained high (139/165, 84%), but 3/165 (2%) recommended complete restriction and 23/165 (14%) restriction based on sport type (primarily from high static and high dynamic sports, 13/23, 57%). With moderate right ventricular outflow tract obstruction, by contrast, 92/164 (56%) supported full participation and 10/164 (6%) complete restriction, with the remaining 62/164 (38%) recommending sport-specific guidance. D-TGA: A similar majority (154/163, 95%) supported full participation for athletes with repaired D-TGA, but this number was considerably lower when with neo-aortic root dilation (4.0 cm) was added to the patient scenario, with only 50/163 (31%) recommending full participation and a majority (104/163, 64%) recommending sport-specific restriction. Notably, only 52/163 (31.9%) supported participation in contact sports in this specific scenario, although willingness to do so was higher (26/59, 44%) among ACHD specialists compared to pediatric cardiologists (23/95, 25%) (p=0.02). Conclusion: While the vast majority of providers support full sports participation in repaired TOF and D-TGA without residual issues, there is heterogeneity in guidance regarding sports participation in those with post repair issues. This marks an important area for future quality initiatives to ensure alignment with expert guidelines.
Steinmetz, Kristen
( Massachusetts General Hospital
, Boston
, Massachusetts
, United States
)
Petek, Bradley
( Oregon Health Science University
, Portland
, Oregon
, United States
)
Churchill, Timothy
( Massachusetts General Hospital
, Boston
, Massachusetts
, United States
)
Dean, Peter
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Edelson, Jonathan
( CHILDRENS HOSPITAL OF PHILADELPHIA
, Philadelphia
, Pennsylvania
, United States
)
Flack, English C
( Vanderbilt University
, Nashville
, Tennessee
, United States
)
Mcgrath, Lidija
( Oregon Health and Science Universit
, Portland
, Texas
, United States
)
Moulson, Nathaniel
( University of British Columbia
, Vancouver
, British Columbia
, Canada
)
Shafer, Keri
( University of Texas Southwestern
, Dallas
, Texas
, United States
)
Weller, Samantha
( Oregon Health Science University
, Portland
, Oregon
, United States
)
Author Disclosures:
Kristen Steinmetz:DO NOT have relevant financial relationships
| Bradley Petek:DO NOT have relevant financial relationships
| Timothy Churchill:No Answer
| Peter Dean:DO NOT have relevant financial relationships
| Jonathan Edelson:DO have relevant financial relationships
;
Consultant:abiomed :Past (completed)
; Speaker:medtronic:Past (completed)
| English C Flack:No Answer
| Lidija McGrath:DO NOT have relevant financial relationships
| Nathaniel Moulson:DO have relevant financial relationships
;
Research Funding (PI or named investigator):VCHRI:Active (exists now)
; Speaker:Novartis:Past (completed)
; Research Funding (PI or named investigator):Amgen:Active (exists now)
; Advisor:HLS Therapeutics :Past (completed)
; Advisor:NovoNordisk:Past (completed)
; Speaker:NovoNordisk:Past (completed)
| Keri Shafer:No Answer
| Samantha Weller:DO NOT have relevant financial relationships